BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burgess CR, Tse G, Gillis L, Peever JH. Dopaminergic regulation of sleep and cataplexy in a murine model of narcolepsy. Sleep 2010;33:1295-304. [PMID: 21061851 DOI: 10.1093/sleep/33.10.1295] [Cited by in Crossref: 37] [Cited by in F6Publishing: 35] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Dauvilliers Y, Tafti M, Landolt HP. Catechol-O-methyltransferase, dopamine, and sleep-wake regulation. Sleep Medicine Reviews 2015;22:47-53. [DOI: 10.1016/j.smrv.2014.10.006] [Cited by in Crossref: 39] [Cited by in F6Publishing: 36] [Article Influence: 5.6] [Reference Citation Analysis]
2 Siembida J, Karakuła K. GHB receptors - a new trend in psychopharmacology? Current Problems of Psychiatry 2018;19:285-98. [DOI: 10.2478/cpp-2018-0023] [Reference Citation Analysis]
3 Lopez R, Dauvilliers Y. Pharmacotherapy options for cataplexy. Expert Opin Pharmacother 2013;14:895-903. [PMID: 23521426 DOI: 10.1517/14656566.2013.783021] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.9] [Reference Citation Analysis]
4 Seifinejad A, Vassalli A, Tafti M. Neurobiology of cataplexy. Sleep Med Rev 2021;60:101546. [PMID: 34607185 DOI: 10.1016/j.smrv.2021.101546] [Reference Citation Analysis]
5 Hasegawa E, Miyasaka A, Sakurai K, Cherasse Y, Li Y, Sakurai T. Rapid eye movement sleep is initiated by basolateral amygdala dopamine signaling in mice. Science 2022;375:994-1000. [PMID: 35239361 DOI: 10.1126/science.abl6618] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Heifetz A, Morris GB, Biggin PC, Barker O, Fryatt T, Bentley J, Hallett D, Manikowski D, Pal S, Reifegerste R, Slack M, Law R. Study of Human Orexin-1 and -2 G-Protein-Coupled Receptors with Novel and Published Antagonists by Modeling, Molecular Dynamics Simulations, and Site-Directed Mutagenesis. Biochemistry 2012;51:3178-97. [DOI: 10.1021/bi300136h] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.1] [Reference Citation Analysis]
7 Snow MB, Fraigne JJ, Thibault-Messier G, Chuen VL, Thomasian A, Horner RL, Peever J. GABA Cells in the Central Nucleus of the Amygdala Promote Cataplexy. J Neurosci 2017;37:4007-22. [PMID: 28209737 DOI: 10.1523/JNEUROSCI.4070-15.2017] [Cited by in Crossref: 23] [Cited by in F6Publishing: 11] [Article Influence: 4.6] [Reference Citation Analysis]
8 Szabo ST, Thorpy MJ, Mayer G, Peever JH, Kilduff TS. Neurobiological and immunogenetic aspects of narcolepsy: Implications for pharmacotherapy. Sleep Med Rev 2019;43:23-36. [PMID: 30503715 DOI: 10.1016/j.smrv.2018.09.006] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 7.5] [Reference Citation Analysis]
9 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Yang J, Gao J. Solriamfetol for the treatment of excessive daytime sleepiness associated with narcolepsy. Expert Review of Clinical Pharmacology 2019;12:723-8. [DOI: 10.1080/17512433.2019.1632705] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Brooks PL, Peever JH. Identification of the transmitter and receptor mechanisms responsible for REM sleep paralysis. J Neurosci 2012;32:9785-95. [PMID: 22815493 DOI: 10.1523/JNEUROSCI.0482-12.2012] [Cited by in Crossref: 86] [Cited by in F6Publishing: 37] [Article Influence: 8.6] [Reference Citation Analysis]
12 Qiu MH, Yao QL, Vetrivelan R, Chen MC, Lu J. Nigrostriatal Dopamine Acting on Globus Pallidus Regulates Sleep. Cereb Cortex 2016;26:1430-9. [PMID: 25316334 DOI: 10.1093/cercor/bhu241] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 4.9] [Reference Citation Analysis]
13 Liu Y, Wang T, Zhou J, Qu W, Huang Z. Dopamine D1 and D2 receptors mediate analgesic and hypnotic effects of l-tetrahydropalmatine in a mouse neuropathic pain model. Psychopharmacology 2019;236:3169-82. [DOI: 10.1007/s00213-019-05275-3] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 4.3] [Reference Citation Analysis]
14 Plazzi G, Pizza F, Palaia V, Franceschini C, Poli F, Moghadam KK, Cortelli P, Nobili L, Bruni O, Dauvilliers Y, Lin L, Edwards MJ, Mignot E, Bhatia KP. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy. Brain 2011;134:3477-89. [PMID: 21930661 DOI: 10.1093/brain/awr244] [Cited by in Crossref: 103] [Cited by in F6Publishing: 90] [Article Influence: 9.4] [Reference Citation Analysis]
15 Dauvilliers Y, Bogan RK, Šonka K, Partinen M, Foldvary-schaefer N, Thorpy MJ. Calcium, Magnesium, Potassium, and Sodium Oxybates Oral Solution: A Lower-Sodium Alternative for Cataplexy or Excessive Daytime Sleepiness Associated with Narcolepsy. NSS 2022;Volume 14:531-46. [DOI: 10.2147/nss.s279345] [Reference Citation Analysis]
16 Liblau RS, Vassalli A, Seifinejad A, Tafti M. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015;14:318-28. [PMID: 25728441 DOI: 10.1016/S1474-4422(14)70218-2] [Cited by in Crossref: 107] [Cited by in F6Publishing: 34] [Article Influence: 15.3] [Reference Citation Analysis]
17 Black SW, Schwartz MD, Chen TM, Hoener MC, Kilduff TS. Trace Amine-Associated Receptor 1 Agonists as Narcolepsy Therapeutics. Biol Psychiatry 2017;82:623-33. [PMID: 27919403 DOI: 10.1016/j.biopsych.2016.10.012] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 4.7] [Reference Citation Analysis]
18 Hyacinthe C, Barraud Q, Tison F, Bezard E, Ghorayeb I. D1 receptor agonist improves sleep-wake parameters in experimental parkinsonism. Neurobiol Dis 2014;63:20-4. [PMID: 24211719 DOI: 10.1016/j.nbd.2013.10.029] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
19 Huang B, Qian Z, Wang Z, Zhang J, Chen K, Xu T, Wang J, Cechetto DF, Zhao Z, Wu H. Fluctuation of primary motor cortex excitability during cataplexy in narcolepsy. Ann Clin Transl Neurol 2019;6:210-21. [PMID: 30847354 DOI: 10.1002/acn3.670] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
20 Brooks PL, Peever JH. Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice. J Neurosci 2011;31:7111-21. [PMID: 21562273 DOI: 10.1523/JNEUROSCI.0347-11.2011] [Cited by in Crossref: 77] [Cited by in F6Publishing: 34] [Article Influence: 7.0] [Reference Citation Analysis]
21 Hasegawa E, Yanagisawa M, Sakurai T, Mieda M. Orexin neurons suppress narcolepsy via 2 distinct efferent pathways. J Clin Invest 2014;124:604-16. [PMID: 24382351 DOI: 10.1172/JCI71017] [Cited by in Crossref: 96] [Cited by in F6Publishing: 49] [Article Influence: 12.0] [Reference Citation Analysis]
22 Black SW, Morairty SR, Fisher SP, Chen TM, Warrier DR, Kilduff TS. Almorexant promotes sleep and exacerbates cataplexy in a murine model of narcolepsy. Sleep 2013;36:325-36. [PMID: 23449602 DOI: 10.5665/sleep.2442] [Cited by in Crossref: 38] [Cited by in F6Publishing: 40] [Article Influence: 4.2] [Reference Citation Analysis]
23 Fraigne JJ, Torontali ZA, Snow MB, Peever JH. REM Sleep at its Core - Circuits, Neurotransmitters, and Pathophysiology. Front Neurol 2015;6:123. [PMID: 26074874 DOI: 10.3389/fneur.2015.00123] [Cited by in Crossref: 67] [Cited by in F6Publishing: 57] [Article Influence: 9.6] [Reference Citation Analysis]
24 Katzav A, Arango MT, Kivity S, Tanaka S, Givaty G, Agmon-levin N, Honda M, Anaya J, Chapman J, Shoenfeld Y. Passive transfer of narcolepsy: Anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. Journal of Autoimmunity 2013;45:24-30. [DOI: 10.1016/j.jaut.2013.06.010] [Cited by in Crossref: 42] [Cited by in F6Publishing: 39] [Article Influence: 4.7] [Reference Citation Analysis]
25 Torontali ZA, Fraigne JJ, Sanghera P, Horner R, Peever J. The Sublaterodorsal Tegmental Nucleus Functions to Couple Brain State and Motor Activity during REM Sleep and Wakefulness. Curr Biol 2019;29:3803-3813.e5. [PMID: 31679942 DOI: 10.1016/j.cub.2019.09.026] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
26 Adamantidis AR, Schmidt MH, Carter ME, Burdakov D, Peyron C, Scammell TE. A circuit perspective on narcolepsy. Sleep 2020;43:zsz296. [PMID: 31919524 DOI: 10.1093/sleep/zsz296] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
27 Gotter AL, Webber AL, Coleman PJ, Renger JJ, Winrow CJ. International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and Pharmacology. Pharmacol Rev 2012;64:389-420. [DOI: 10.1124/pr.111.005546] [Cited by in Crossref: 114] [Cited by in F6Publishing: 107] [Article Influence: 11.4] [Reference Citation Analysis]
28 Videnovic A, Golombek D. Circadian and sleep disorders in Parkinson's disease. Exp Neurol 2013;243:45-56. [PMID: 22935723 DOI: 10.1016/j.expneurol.2012.08.018] [Cited by in Crossref: 140] [Cited by in F6Publishing: 113] [Article Influence: 14.0] [Reference Citation Analysis]
29 Schwartz MD, Canales JJ, Zucchi R, Espinoza S, Sukhanov I, Gainetdinov RR. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases. Expert Opinion on Therapeutic Targets 2018;22:513-26. [DOI: 10.1080/14728222.2018.1480723] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 6.5] [Reference Citation Analysis]
30 Del Cid-Pellitero E, Garzón M. Hypocretin1/orexinA-immunoreactive axons form few synaptic contacts on rat ventral tegmental area neurons that project to the medial prefrontal cortex. BMC Neurosci 2014;15:105. [PMID: 25194917 DOI: 10.1186/1471-2202-15-105] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
31 Blanco-Centurion C, Liu M, Konadhode R, Pelluru D, Shiromani PJ. Effects of orexin gene transfer in the dorsolateral pons in orexin knockout mice. Sleep 2013;36:31-40. [PMID: 23288969 DOI: 10.5665/sleep.2296] [Cited by in Crossref: 23] [Cited by in F6Publishing: 26] [Article Influence: 2.6] [Reference Citation Analysis]
32 Burgess C, Peever J. A Noradrenergic Mechanism Functions to Couple Motor Behavior with Arousal State. Current Biology 2013;23:1719-25. [DOI: 10.1016/j.cub.2013.07.014] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 3.4] [Reference Citation Analysis]
33 Peyron C, Arthaud S, Villalba M, Fort P. Defining and measuring paradoxical (REM) sleep in animal models of sleep disorders. Current Opinion in Physiology 2020;15:203-9. [DOI: 10.1016/j.cophys.2020.03.008] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Baladi MG, Forster MJ, Gatch MB, Mailman RB, Hyman DL, Carter LP, Janowsky A. Characterization of the Neurochemical and Behavioral Effects of Solriamfetol (JZP-110), a Selective Dopamine and Norepinephrine Reuptake Inhibitor. J Pharmacol Exp Ther 2018;366:367-76. [PMID: 29891587 DOI: 10.1124/jpet.118.248120] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 11.8] [Reference Citation Analysis]
35 Dauvilliers Y, Siegel JM, Lopez R, Torontali ZA, Peever JH. Cataplexy—clinical aspects, pathophysiology and management strategy. Nat Rev Neurol 2014;10:386-95. [DOI: 10.1038/nrneurol.2014.97] [Cited by in Crossref: 103] [Cited by in F6Publishing: 77] [Article Influence: 12.9] [Reference Citation Analysis]
36 Eban-Rothschild A, Rothschild G, Giardino WJ, Jones JR, de Lecea L. VTA dopaminergic neurons regulate ethologically relevant sleep-wake behaviors. Nat Neurosci 2016;19:1356-66. [PMID: 27595385 DOI: 10.1038/nn.4377] [Cited by in Crossref: 228] [Cited by in F6Publishing: 196] [Article Influence: 38.0] [Reference Citation Analysis]
37 Black SW, Yamanaka A, Kilduff TS. Challenges in the development of therapeutics for narcolepsy. Prog Neurobiol 2017;152:89-113. [PMID: 26721620 DOI: 10.1016/j.pneurobio.2015.12.002] [Cited by in Crossref: 32] [Cited by in F6Publishing: 27] [Article Influence: 4.6] [Reference Citation Analysis]
38 Kirshenbaum G, Burgess C, Déry N, Fahnestock M, Peever J, Roder J. Attenuation of mania-like behavior in Na+,K+-ATPase α3 mutant mice by prospective therapies for bipolar disorder: Melatonin and exercise. Neuroscience 2014;260:195-204. [DOI: 10.1016/j.neuroscience.2013.12.011] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
39 Pintwala S, Peever J. Circuit mechanisms of sleepiness and cataplexy in narcolepsy. Current Opinion in Neurobiology 2017;44:50-8. [DOI: 10.1016/j.conb.2017.02.010] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
40 Wang C, Wang Q, Ji B, Pan Y, Xu C, Cheng B, Bai B, Chen J. The Orexin/Receptor System: Molecular Mechanism and Therapeutic Potential for Neurological Diseases. Front Mol Neurosci 2018;11:220. [PMID: 30002617 DOI: 10.3389/fnmol.2018.00220] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 13.8] [Reference Citation Analysis]
41 Morin LP. A Path to Sleep Is through the Eye. eNeuro 2015;2:ENEURO. [PMID: 26464977 DOI: 10.1523/ENEURO.0069-14.2015] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]